Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Artesunate in Kenyan Adults With Uncomplicated Malaria
NCT00298610Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Mar 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of artesunate in Malaria, sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Change in Percentage of Parasites Detected at 48 Hours. Started Mar 2006; status: completed.
02
Drugs
artesunate
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00298610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298610.